Aseem Pandey

6.6k total citations
16 papers, 393 citations indexed

About

Aseem Pandey is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Aseem Pandey has authored 16 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Aseem Pandey's work include Influenza Virus Research Studies (6 papers), Viral gastroenteritis research and epidemiology (5 papers) and Respiratory viral infections research (4 papers). Aseem Pandey is often cited by papers focused on Influenza Virus Research Studies (6 papers), Viral gastroenteritis research and epidemiology (5 papers) and Respiratory viral infections research (4 papers). Aseem Pandey collaborates with scholars based in United States, Japan and China. Aseem Pandey's co-authors include Neetu Singh, Suresh K. Mittal, Lakshmi Jayashankar, Jacqueline M. Katz, Suryaprakash Sambhara, Rubén O. Donis, Sai Vikram Vemula, Laurent L. Couëtil, Manish Tandon and Anurag Sharma and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Aseem Pandey

16 papers receiving 382 citations

Peers

Countries citing papers authored by Aseem Pandey

Since Specialization

Citations

This map shows the geographic impact of Aseem Pandey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aseem Pandey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aseem Pandey more than expected).

Fields of papers citing papers by Aseem Pandey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aseem Pandey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aseem Pandey. The network helps show where Aseem Pandey may publish in the future.

Co-authorship network of co-authors of Aseem Pandey

This figure shows the co-authorship network connecting the top 25 collaborators of Aseem Pandey. A scholar is included among the top collaborators of Aseem Pandey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aseem Pandey. Aseem Pandey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial 2023 ·Vaccine ·(unknown), (unknown), Hideaki Nagai, Osamu Matsuoka, Satoshi Inoue, Takahiro Inoue, Anju Shrestha, Aseem Pandey, Lee-Jah Chang, (unknown)	7
2	Interactions between fungal hyaluronic acid and host CD44 promote internalization by recruiting host autophagy proteins to forming phagosomes 2021 ·iScience ·Shengli Ding, Jing Yang, Xuehuan Feng, Aseem Pandey, Rola Barhoumi, Dongmei Zhang, Samantha L. Bell, Yue Liu, Luciana Fachini da Costa, Allison C. Rice‐Ficht, Robert O. Watson, Kristin L. Patrick, Qing‐Ming Qin, Thomas A. Ficht, Paul de Figueiredo	4
3	Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial 2021 ·Vaccine ·Lee-Jah Chang, Evan J. Anderson, Robert Jeanfreau, Ying He, (unknown), Anju Shrestha, Aseem Pandey, Victoria Landolfi, (unknown)	1
4	Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial 2019 ·Human Vaccines & Immunotherapeutics ·(unknown), Osamu Matsuoka, Satoshi Inoue, Takahiro Inoue, (unknown), (unknown), Kumiko Kato, Aseem Pandey, Lee-Jah Chang	15
5	Activation of Host IRE1α-Dependent Signaling Axis Contributes the Intracellular Parasitism of Brucella melitensis 2018 ·Frontiers in Cellular and Infection Microbiology ·Aseem Pandey, Furong Lin, (unknown), Luciana Fachini da Costa, Xuehuan Feng, (unknown), Mingzhe Zhang, Takao Iwawaki, Allison C. Rice‐Ficht, Thomas A. Ficht, Paul de Figueiredo, Qing‐Ming Qin	20
6	Rapamycin Does Not Impede Survival or Induction of Antibody Responses to Primary and Heterosubtypic Influenza Infections in Mice 2016 ·Viral Immunology ·Justine S. Liepkalns, Aseem Pandey, Amelia R. Hofstetter, Amrita Kumar, (unknown), Weiping Cao, Feng Liu, Min Z. Levine, Suryaprakash Sambhara, Shivaprakash Gangappa	3
7	The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis 2016 ·PLoS neglected tropical diseases ·Aseem Pandey, (unknown), Lavoisier Akoolo, Allison C. Rice‐Ficht, Ángela M. Arenas-Gamboa, David N. McMurray, Thomas A. Ficht, Paul de Figueiredo	19
8	siRNA Screens Using Drosophila Cells to Identify Host Factors Required for Infection 2014 ·Methods in molecular biology ·Aseem Pandey, Sheng Ding, Thomas A. Ficht, Paul de Figueiredo	2
9	Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice 2013 ·Virus Research ·Sai Vikram Vemula, Aseem Pandey, Neetu Singh, Jacqueline M. Katz, Rubén O. Donis, Suryaprakash Sambhara, Suresh K. Mittal	8
10	Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine 2012 ·PLoS ONE ·Aseem Pandey, Neetu Singh, Sai Vikram Vemula, Laurent L. Couëtil, Jacqueline M. Katz, Rubén O. Donis, Suryaprakash Sambhara, Suresh K. Mittal	61
11	Rapid Differentiation of Monocytes into Type I IFN-Producing Myeloid Dendritic Cells as an Antiviral Strategy against Influenza Virus Infection 2012 ·The Journal of Immunology ·Weiping Cao, (unknown), (unknown), William G. Davis, Jin Hyang Kim, A. Reber, Tatiana Chirkova, Juan A. De La Cruz, Aseem Pandey, Priya Ranjan, Jacqueline M. Katz, Shivaprakash Gangappa, Suryaprakash Sambhara	45
12	Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses 2010 ·Human Vaccines ·Aseem Pandey, Neetu Singh, (unknown)	40
13	Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target 2010 ·Expert Reviews in Molecular Medicine ·Neetu Singh, Aseem Pandey, Suresh K. Mittal	21
14	Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model 2009 ·Virology ·Anurag Sharma, Dinesh S. Bangari, Manish Tandon, Aseem Pandey, Harm HogenEsch, Suresh K. Mittal	41
15	A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses 2008 ·The Journal of Infectious Diseases ·Mary Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, (unknown), Jacqueline M. Katz, Rubén O. Donis, Suresh K. Mittal, Suryaprakash Sambhara	50
16	Bovine Adenoviral Vector–based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus 2008 ·Molecular Therapy ·Neetu Singh, Aseem Pandey, Lakshmi Jayashankar, Suresh K. Mittal	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact